-+ 0.00%
-+ 0.00%
-+ 0.00%

Community Health Systems (CYH) Stock Price Sinks As Q3 Results Cut Deeper

Simply Wall St·10/30/2026 01:35:49
Listen to the news

Community Health Systems just released its Q3 2026 scorecard and the share price reaction was brutal. The stock closed at US$2.41, down 9.4% on the day. That move appears driven more by panic than by precision.

The headline is simple. A swing back to a quarterly net loss of US$86 million and basic earnings per share of US$0.63 in the red coincided with lowered full year EBITDA guidance and a heavier leverage ratio of 7.2x. Traders focused on the profit squeeze and the debt load. The fuller picture is more complicated than a one day selloff suggests.

Like the hospital footprint and revenue base at Community Health Systems but uneasy about the leverage and renewed losses? Check out the list of solid balance sheet and fundamentals stocks (22 results) for examples of businesses that pair robust operations with far stronger balance sheets.

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): US$2,757 million vs. US$3,087 million (fell 10.7%)
  • Net Income/Loss (Q3 2026 vs. Q3 2025): Net loss of US$86 million vs. net income of US$130 million (swung from profit to loss)
  • Basic EPS (Q3 2026 vs. Q3 2025): loss of US$0.63 per share vs. earnings of US$0.97 per share (moved from positive to negative)
  • Adjusted EBITDA Margin (Q3 2026 vs. Q3 2025): 10.2% vs. 12.2% (compressed by 2.0 percentage points)

Leverage climbed even after $800M of debt paydown. Ask Charlie what’s really driving Community Health Systems’ rising leverage.

NYSE:CYH Trailing 12-Month Earnings & Revenue History as at Oct 2026
NYSE:CYH Trailing 12-Month Earnings & Revenue History as at Oct 2026

Evaluating Whether CYH’s Bull Case Is Showing Up Yet

The bullish script says Community Health Systems can use outpatient growth and efficiency gains to blunt payer mix and cost pressure.

"The main factor that has to go right is that outpatient growth, portfolio pruning and tech-enabled efficiency continue to offset pressure from softer elective volumes, heavier self-pay mix and higher specialist fees."

Q3 shows partial progress rather than a clean win. Same store admissions and clinic visits rose and operating expense per adjusted admission stayed near flat in real terms, which supports the efficiency story. Yet adjusted EBITDA margin fell 2 percentage points and leverage moved to 7.2x. As a result, the benefits are not yet fully offsetting mix and specialist headwinds.

The price and this Narrative do not agree. → Uncover what this Narrative says Community Health Systems is actually worth.

CYH Bear Case On Mix And Cash Still Bites

The concern is that softer surgical mix, heavier uninsured traffic and working capital friction may keep Community Health Systems operating on thin margins despite cost work.

"While Medicare Advantage and commercial payers continue to pay claims, the shift toward pre payment audits and expanded documentation requests is lengthening collection cycles and driving higher days in accounts receivable."

Q3 results do not resolve that concern. Management noted weaker self pay collections, uninsured ER growth and days in accounts receivable that are only stable, not improving, alongside compressed EBITDA margin and leverage of 7.2x.

Hunt For Mispriced Earnings Power

Community Health Systems highlights how headline losses and leverage can dominate the short term narrative. The real opportunity could be in stocks that could be undervalued before the market reassesses their earnings power.

  • Company 1 - 32% below our estimate - anchors the software and chip platform supporting high yield AI data centers for major cloud buyers.
  • Company 2 - 15% below our estimate - builds electrical and communications systems contractors use for hyperscale data center projects and construction pipelines.
  • Company 3 - 20% below our estimate - scales a franchise and company operated teahouse network as overseas locations reshape mix and unit economics.

Three companies from the same screener. Open all 30 potentially undervalued companies →